45 results
6-K
EX-99
BLRX
Bioline Rx Ltd
27 Sep 22
BioLineRx Announces U.S. Commercialization Plan for APHEXDA (Motixafortide) in Stem Cell Mobilization
7:00am
to accelerate availability to patients and maximize value through
independent commercialization
to well-defined U.S. transplant center community … and targeted sales force to support outreach to this well-defined community.
“We are excited to announce our plan to commercialize Motixafortide, now known
6-K
EX-99
BLRX
Bioline Rx Ltd
7 Aug 18
BioLineRx Announces Positive Results of Lead-in Period
7:00am
, will be of great value to patients as well as to the medical community. I am looking forward to participating in the trial and to potentially
6-K
EX-99
BLRX
Bioline Rx Ltd
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
, if corroborated in the placebo-controlled part of the trial, will be of great value to patients as well as to the medical community.”
The results
6-K
EX-99
BLRX
Bioline Rx Ltd
21 Dec 23
BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating
7:05am
FDA approvals of two gene therapies for sickle cell disease in the U.S. is an exciting development for the sickle cell community, and we are eager
F-1
EX-10.15
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
the scientific community in Israel aware of the Program. All print and electronic publications about the Program will include a reference to the fact
20FR12B
EX-4.15
r63a vtap4
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
6-K
EX-99
gtxz9k6
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
20-F
q05f2v6zxd 1og
22 Mar 12
Annual report (foreign)
12:00am
20FR12B
zhb0g6gu86
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
424B3
yxyzxzw95 iusv
28 Mar 12
Prospectus supplement
12:00am
F-1
11ahxen
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B/A
2o3hncvi97nzxoj
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
424B3
0hwd7edppfwmrfclc
15 Oct 12
Prospectus supplement
12:00am
F-1
gl84hfi04i
2 Oct 12
Registration statement (foreign)
12:00am
20-F/A
8xo ggy5a2g
26 Mar 24
Annual report (foreign) (amended)
4:57pm
F-3/A
EX-4.2
38rquw
13 Aug 12
Shelf registration (foreign) (amended)
12:00am
F-1
EX-10.17
ib8cv5nf8mhtxb0x1cn5
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.17
tweycyozsfii87xuu
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am